Standard BioTools Inc
NASDAQ:LAB

Watchlist Manager
Standard BioTools Inc Logo
Standard BioTools Inc
NASDAQ:LAB
Watchlist
Price: 2.15 USD -1.38% Market Closed
Market Cap: 798m USD
Have any thoughts about
Standard BioTools Inc?
Write Note

Net Margin
Standard BioTools Inc

-120.8%
Current
-101%
Average
-0.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-120.8%
=
Net Income
-164.7m
/
Revenue
136.3m

Net Margin Across Competitors

Country US
Market Cap 795.3m USD
Net Margin
-121%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 210.8B USD
Net Margin
14%
Country US
Market Cap 177.2B USD
Net Margin
18%
Country KR
Market Cap 71.2T KRW
Net Margin
24%
Country CH
Market Cap 39.6B CHF
Net Margin
9%
Country US
Market Cap 39.8B USD
Net Margin
9%
Country US
Market Cap 39.3B USD
Net Margin
22%
Country US
Market Cap 27.8B USD
Net Margin
21%
Country US
Market Cap 24.1B USD
Net Margin
-36%
Country US
Market Cap 23.5B USD
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Standard BioTools Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-120.8%
=
Net Income
-164.7m
/
Revenue
136.3m
What is the Net Margin of Standard BioTools Inc?

Based on Standard BioTools Inc's most recent financial statements, the company has Net Margin of -120.8%.